Papers - NISHIDA, Yoshihiro
-
Effects of ultraviolet irradiation with a LED device on bone metabolism associated with vitamin D deficiency in senescence-accelerated mouse P6 Reviewed
Morita D, Higuchi Y, Makida K, Seki T, Ikuta K, Ishiguro N, Nishida Y
Heliyon Vol. 6 ( 2 ) page： e03499 2020.2
-
Targetable driver mutations in multicentric reticulohistiocytosis. Reviewed
Murakami N, Sakai T, Arai E, Muramatsu H, Ichikawa D, Asai S, Shimoyama Y, Ishiguro N, Takahashi Y, Okuno Y, Nishida Y
Haematologica Vol. 105 ( 2 ) page： e61-e64 2020.1
-
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Reviewed
Desmoid Tumor Working Group. (Alman B, Nishida Y, et al)
Eur J Cancer. Vol. 127 page： 96-107 2020.1
-
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Reviewed
Heng M, Gupta A, Chung PW, Healey JH, Vaynrub M, Rose PS, Houdek MT, Lin PP, Bishop AJ, Hornicek FJ, Chen YL, Lozano-Calderon S, Holt GE, Han I, Biau D, Niu X, Bernthal NM, Ferguson PC, Wunder JS; Japanese Musculoskeletal Oncology Group (JMOG, Nishida Y included); Soft Tissue Osteosarcoma International Collaborative (STOIC).
Eur J Cancer. Vol. 125 page： 130-141 2020.1
-
Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations. Reviewed
Tsuda Y, Hirata M, Katayama K, Motoi T, Matsubara D, Oda Y, Fujita M, Kobayashi H, Kawano H, Nishida Y, Sakai T, Okuma T, Goto T, Ogura K, Kawai A, Ae K, Anazawa U, Suehara Y, Iwata S, Miyano S, Imoto S, Shibata T, Nakagawa H, Yamaguchi R, Tanaka S, Matsuda K
International journal of cancer Vol. 145 ( 12 ) page： 3276 - 3284 2019.12
-
Integrated Exome and RNA Sequencing of Dedifferentiated Liposarcoma. Reviewed
Makoto Hirata, Naofumi Asano, Kotoe Katayama, Akihiko Yoshida, Yusuke Tsuda, Masaya Sekimizu, Sachiyo Mitani, Eisuke Kobayashi, Motokiyo Komiyama, Hiroyuki Fujimoto, Takahiro Goto, Yukihide Iwamoto, Norifumi Naka, Shintaro Iwata, Yoshihiro Nishida, Toru Hiruma, Hiroaki Hiraga, Hirotaka Kawano, Toru Motoi, Yoshinao Oda, Daisuke Matsubara, Masashi Fujita, Tatsuhiro Shibata, Hidewaki Nakagawa, Robert Nakayama, Tadashi Kondo, Seiya Imoto, Satoru Miyano, Akira Kawai, Rui Yamaguchi, Hitoshi Ichikawa, and Koichi Matsuda
Nat Commun Vol. 10 ( 1 ) page： 5683 2019.12
-
Clinical Frailty Scale Score Before ICU Admission Is Associated With Mobility Disability in Septic Patients Receiving Early Rehabilitation. Reviewed
Nakajima H, Nishikimi M, Shimizu M, Hayashi K, Inoue T, Nishida K, Takahashi K, Matsui S, Nishida Y, Matsuda N.
Crit Care Explor. Vol. 1 ( 12 ) page： e0066 2019.12
-
MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis Reviewed
Shimizu Koki, Hamada Shunsuke, Sakai Tomohisa, Ito Shinji, Urakawa Hiroshi, Arai Eisuke, Ikuta Kunihiro, Koike Hiroshi, Ishiguro Naoki, Nishida Yoshihiro
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY Vol. 63 ( 6 ) page： 751-757 2019.12
-
Clinical Features of Thoracic Myelopathy: A Single-Center Study. Reviewed
Ando K, Imagama S, Kobayashi K, Ito K, Tsushima M, Morozumi M, Tanaka S, Machino M, Ota K, Nakashima H, Nishida Y, Ishiguro N.
J Am Acad Orthop Surg Glob Res Rev. Vol. 3 ( 11 ) page： - 2019.11
-
Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan. Reviewed
Nishida Y, Kawai A, Toguchida J, Ogose A, Ae K, Kunisada T, Matsumoto Y, Matsunobu T, Takahashi K, Nishida K, Ozaki T
International journal of clinical oncology Vol. 24 ( 11 ) page： 1498-0505 2019.11
-
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost. Reviewed
Nishida Y, Sakai T, Koike H, Ito K.
Lancet Oncol. Vol. 20 ( 10 ) page： e555 2019.10
-
Treatment of tenosynovial giant-cell tumour types. Reviewed
Nishida Y, Ikuta K
The Lancet. Oncology Vol. 20 ( 8 ) page： e399 2019.8
-
The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study Reviewed
Nakamura Tomoki, Tsukushi Satoshi, Asanuma Kunihiro, Katagiri Hirohisa, Ikuta Kunihiro, Nagano Akihito, Kozawa Eiji, Yamada Satoshi, Shido Yoji, Yamada Kenji, Kawanami Katsuhisa, Ishimura Daisuke, Sudo Akihiro, Nishida Yoshihiro
CLINICAL & EXPERIMENTAL METASTASIS Vol. 36 ( 4 ) page： 343-350 2019.8
-
Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study. Reviewed
Senda J, Ito K, Kotake T, Kanamori M, Kishimoto H, Kadono I, Nakagawa-Senda H, Wakai K, Katsuno M, Nishida Y, Ishiguro N, Sobue G.
Nagoya J Med Sci. Vol. 81 ( 3 ) page： 359-373 2019.8
-
Frequent mutations of genes encoding vacuolar H+ -ATPase components in granular cell tumors. Reviewed
Sekimizu M, Yoshida A, Mitani S, Asano N, Hirata M, Kubo T, Yamazaki F, Sakamoto H, Kato M, Makise N, Mori T, Yamazaki N, Sekine S, Oda I, Watanabe SI, Hiraga H, Yonemoto T, Kawamoto T, Naka N, Funauchi Y, Nishida Y, Honoki K, Kawano H, Tsuchiya H, Kunisada T, Matsuda K, Inagaki K, Kawai A, Ichikawa H.
Genes Chromosomes Cancer. Vol. 58 ( 6 ) page： 373-380 2019.6
-
Roles of hyaluronan in cardiovascular and nervous system disorders Reviewed
Ding Hong-yan, Xie Ya-nan, Dong Qiang, Kimata Koji, Nishida Yoshihiro, Ishiguro Naoki, Zhuo Li-sheng
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B Vol. 20 ( 5 ) page： 428-436 2019.5
-
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610. Reviewed
Urakawa H, Mizusawa J, Tanaka K, Eba J, Hiraga H, Kawai A, Nishida Y, Hosaka M, Iwamoto Y, Fukuda H, Ozaki T.
Jpn J Clin Oncol. Vol. 49 ( 4 ) page： 379-382 2019.4
-
Fusion surgery with instrumentation following carbon ion radiotherapy for primary lumbar tumors: A case series. Reviewed
Ando K, Kobayashi K, Machino M, Ota K, Morozumi M, Tanaka S, Imai R, Nishida Y, Ishiguro N, Imagama S.
J Clin Neurosci. Vol. 62 page： 264-268 2019.4
-
Successful treatment of a recurrent chest wall desmoid tumor with cyclooxygenase-2 inhibitors. Reviewed
Kaiho T, Nakajima T, Nishida Y, Yoshino I.
J Thorac Cardiovasc Surg. Vol. 157 ( 3 ) page： e195-e197. 2019.3
-
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol. Reviewed
Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.
BMC Musculoskelet Disord. Vol. 20 ( 1 ) page： 68 2019.2